PGI23 TREATMENT COST ANALYSIS FOR PATIENTS IN THE UNITED STATES WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS WHO HAVE AN INADEQUATE RESPONSE OR WHO ARE INTOLERANT TO TNF BLOCKERS
May 1, 2020, 00:00
10.1016/j.jval.2020.04.379
https://www.valueinhealthjournal.com/article/S1098-3015(20)30567-2/fulltext
Title :
PGI23 TREATMENT COST ANALYSIS FOR PATIENTS IN THE UNITED STATES WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS WHO HAVE AN INADEQUATE RESPONSE OR WHO ARE INTOLERANT TO TNF BLOCKERS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)30567-2&doi=10.1016/j.jval.2020.04.379
First page :
Section Title :
Open access? :
No
Section Order :
10246